Frias, J. P., Gonzalez‐Galvez, G., Johnsson, E., Maaske, J., Testa, M. A., Simonson, D. C., . . . Peters, A. L. (2020). Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial. Diabetes Obes Metab.
Chicago Style aipamenaFrias, Juan P., Guillermo Gonzalez‐Galvez, Eva Johnsson, Jill Maaske, Marcia A. Testa, Donald C. Simonson, Nalina Dronamraju, Ricardo Garcia‐Sanchez, and Anne L. Peters. "Efficacy and Safety of Dual Add‐on Therapy With Dapagliflozin Plus Saxagliptin Versus Glimepiride in Patients With Poorly Controlled Type 2 Diabetes On a Stable Dose of Metformin: Results From a 52‐week, Randomized, Active‐controlled Trial." Diabetes Obes Metab 2020.
MLA aipamenaFrias, Juan P., et al. "Efficacy and Safety of Dual Add‐on Therapy With Dapagliflozin Plus Saxagliptin Versus Glimepiride in Patients With Poorly Controlled Type 2 Diabetes On a Stable Dose of Metformin: Results From a 52‐week, Randomized, Active‐controlled Trial." Diabetes Obes Metab 2020.